Point72 Hong Kong’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,607
Closed -$330K 275
2022
Q3
$330K Buy
2,607
+1,883
+260% +$213K 0.01% 908
2022
Q2
$60K Buy
724
+60
+9% +$4.65K ﹤0.01% 1327
2022
Q1
$64K Buy
+664
New +$87.6K ﹤0.01% 1272
2021
Q4
Sell
-500
Closed -$124K 1911
2021
Q3
$124K Buy
500
+283
+130% +$80.9K ﹤0.01% 1286
2021
Q2
$90K Sell
217
-515
-70% -$204K ﹤0.01% 1337
2021
Q1
$286K Buy
732
+58
+9% +$28.6K 0.01% 970
2020
Q4
$378K Buy
674
+37
+6% +$23.4K 0.02% 780
2020
Q3
$445K Sell
637
-678
-52% -$529K 0.05% 316
2020
Q2
$1.04M Buy
1,315
+1,300
+8,667% +$980K 0.12% 209
2020
Q1
$9K Buy
+15
New +$14.6K ﹤0.01% 696
2019
Q2
Sell
-19
Closed -$39K 1129
2019
Q1
$39K Buy
19
+18
+1,800% +$31.7K 0.02% 571
2018
Q4
$1K Buy
+1
New +$1.53K ﹤0.01% 783
2018
Q3
Sell
-41
Closed -$84K 908
2018
Q2
$84K Buy
41
+24
+141% +$54.7K 0.03% 337
2018
Q1
$37K Buy
17
+16
+1,600% +$40.7K 0.02% 525
2017
Q4
$1K Buy
+1
New +$2.03K ﹤0.01% 736
2016
Q2
Sell
-8
Closed -$4K 522
2016
Q1
$4K Hold
8
0.01% 463
2015
Q4
$6K Buy
+8
New +$7.99K 0.02% 332

Other funds holding BLUE

Point72 Hong Kong's BLUE Position: Q4 2022 in Review

Point72 Hong Kong sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 2,607 shares — an estimated $330K sold.

Point72 Hong Kong first reported a position in BLUE in Q4 2015 and held it in 17 quarters. The position peaked at $1.04M in Q2 2020. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

  • Point72 Hong Kong reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,607 bluebird bio shares in Q4 2022, an estimated $330K.
  • Point72 Hong Kong first reported a position in bluebird bio in Q4 2015 and held it in 17 quarters.
  • Point72 Hong Kong's bluebird bio position peaked at $1.04M in Q2 2020.
  • 184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.